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doi:10.1016/j.jtcvs.2008.02.004472 The Journal of Thoracic and CarObjective: The Ross operation remains a controversially discussed procedure,
because concern exists regarding late dilatation of the neoartic root and progressive
regurgitation of the autograft valve. We present our early experience with an external
reinforcement of the autograft, which is inserted into a prosthetic Dacron graft with an
artificial aortic root configuration. This detail should help to prevent neoaortic root di-
latation.
Patients andMethods:Between 2006 and 2007, 12 patients (mean age 166 38 years;
range 15–38 years) underwent a Ross procedure by this technique. Indications were
aortic regurgitation (n5 2), aortic stenosis (n5 5), and combined aortic stenosis and
insufficiency (n 5 5). A bicuspid aortic valve was present in 9 patients. Balloon val-
vuloplasty had been performed in 7 patients. Follow-up was performed by clinical and
echocardiographic examinations.
Results: No early or late deaths occurred in this small series, and freedom from reop-
eration is 100%. Echocardiographic follow-up confirmed absence of aortic insuffi-
ciency in 11 patients after a mean of 11 months (range 2–30 months). In 1 patient,
a small asymmetric regurgitation jet was already observed at discharge echocardiog-
raphy. As expected, no neoaortic root dilatation was observed during follow-up. All
patients are in New York Heart Association class I.
Conclusions: The present technique is a simple and reproducible technical step that
does not require significant additional time. Inclusion of the autograft within a root
prosthesis may be especially indicated in situations known for late autograft dilata-
tion, namely, bicuspid aortic valve, predominant aortic insufficiency, and ascending
aortic enlargement.
T
heRoss procedure is considered a valuable option for aortic valve replacement
in children, adolescents, and younger adult patients. However, this procedure
remains a subject of debate even though large series have shown promising
long-term results. The main advantages of the Ross technique are the use of a patient’s
own valve as the aortic valve substitute, with excellent hemodynamics, low risk of
endocarditis, no need for anticoagulation, and some growth potential in small
children.
However, some surgeons and cardiologists criticize the Ross procedure because it
turns a single valve disease into a double-valve pathology.1,2 Besides the hypothetical
necessity for repetitive interventions on the right ventricular outflow tract (RVOT),
midterm to long-term dilatation of the pulmonary autograft in the aortic position is
another concern because it may lead to progressive regurgitation of the neoaortic
valve when the procedure is performed as a full root replacement.3-6 The Ross proce-
dure may therefore be the source for additional reinterventions of increasing complex-
ity. Hence, some conclude that the long-term performance of the Ross procedure,
especially when performed as a full root implant, is the major drawback of this tech-
nique.1,7diovascular Surgery c August 2008
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RVOT 5 right ventricular outflow tract
This article describes our early experience with external
reinforcement of the autograft, which is inserted into a pros-
thetic Dacron graft that exhibits an aortic root design. This
technical detail should help to prevent neoaortic root dilata-
tion and autograft regurgitation.
Patients and Methods
Between 2006 and 2007, 12 patients (7 male and 5 female; mean age
236 7 years; range 16–38 years) underwent the Ross procedure ac-
cording to the technique presented here. All patients were informed
in depth about the new technical detail of the procedure and gave
consent. The Ethics Committee of University Hospital Berne also
gave approval for the introduction of this modified operative tech-
nique. Patients younger than 16 years were not considered for this
technique but received the standard full root option without rein-
forcement to allow an unrestricted autograft growth.
The indication was pure aortic regurgitation in 2, aortic stenosis
in 5, and combined aortic stenosis and insufficiency in 5 patients. A
bicuspid aortic valve was present in 9 patients and balloon valvulo-
plasty had been performed in 7 patients. The cause of the valve dis-
ease was congenital aortic stenosis in all patients. Preoperatively, 8
patients were in New York Heart Association class II and 4 in class
III. All patients were operated on electively.
All patients were prospectively followed up by clinical and echo-
cardiographic examinations, which were obtained intraoperatively,
before discharge, at 6 months and 1 year, and thereafter yearly. Auto-
graft valve function, homograft or RVOTconduit valve function, and
left ventricular function were assessed by M-mode, 2-dimensional
echocardiography, and by color flow Doppler sonography.
Operative Technique
All patients were operated on with moderate hypothermic cardiopul-
monary bypass and intermittent blood cardioplegia. The autograft
root was harvested as described in the original technique with a short
muscular rim of RVOT. The diameter of the autograft was deter-
mined by standard valve sizers and, subsequently, a 2- to 5-mm
larger polyester Valsalva vascular prosthesis (Vascutek woven poly-
ester graft Gelweave; Terumo Cardiovascular Systems Inc, Ann
Arbor, Mich) was chosen.
After the prosthesis has been tailored to an appropriate length by
leaving only a small rim of about 2 to 3 mm of the proximal skirt
(proximal to the artificial root), the autograft is inserted into the vas-
cular prosthesis and fixed with a running suture of 4–0 Prolene poly-
propylene (Ethicon, Inc, Somerville, NJ) at the distal and proximal
ends (Figure 1). If the height of the autograft is smaller than the Val-
salva part of the prosthesis, the proximal skirt can be completely
removed to preserve an ‘‘artificial’’ sinotubular junction at the level
of the commissures of the autograft. Afterward, a standard technique
of complete root replacement is used. The reinforced autograft is
sutured at the annular level of the excised aortic valve with contin-
uous running polypropylene. After careful determination of the
optimal site for coronary ostial reimplantation, small windows areThe Journal of Thomade into the graft and corresponding buttonholes into the wall of
the pulmonary artery (neoaortic root) with an aortic punch. The cor-
onary arteries are reimplanted with a 6–0 running suture between the
coronaries and the autograft only; the graft is not included in this
suture to avoid blood accumulation between the autograft and the
vascular graft in case oozing should occur early postoperatively
(Figure 2). The RVOT is reconstructed with a pulmonary homograft
in a conventional fashion, usually during reperfusion.
In 4 patients, the ascending aorta was replaced with the tubular
part of the Vascutek graft, being reanastomosed to the neoaortic
Valsalva prosthesis after the root procedure (Table 1).
Early Results
Hospital mortality was 0%. Re-exploration because of bleeding was
necessary in 1 patient.
There were no other complications. During early follow-up (up
to 30 months so far) no patient required reoperation. Echocardio-
graphic follow-up confirmed absence of aortic insufficiency in 11
patients after a mean of 12months (range 2–30months). In 1 patient,
an asymmetric regurgitation jet was already observed at discharge
echocardiography but had not increased at 1-year follow-up. As ex-
pected, no neoaortic root dilatation was observed during follow-up.
All patients are in New York Heart Association class I.
Magnetic resonance imaging was performed in 8 of 12 patients
and shows physiologic flow dynamics across the pulmonary auto-
graft, very similar to those found in a normal aortic root of healthy
control subjects.8
Discussion
One of the most important concerns regarding the Ross pro-
cedure is the fact that the pulmonary autograft is exposed
to systemic pressure. A substantial number of articles thus
report a progressive dilatation of the neoaortic root with
consecutive autograft insufficiency in the long term.
Recently, Klieverik and associates7 revealed a worrisome
69%6 7% rate of freedom from autograft reintervention at 13
years’ follow-up. Autograft replacement owing to neoaortic
root dilatation was necessary in 22 of 146 patients during
a mean follow-up of 8.7 years. Similar rates were observed
by Kouchoukos,9 Pasquali,6 and their associates, whereas
other studies reported lower rates of reinterventions for auto-
graft dilatation.10,11 Yacoub and colleagues,10 for instance,
reported a freedom from autograft reoperation of 92.9% at
10 years with a mean follow-up of 6.2 years. In the most re-
cent published series, Pasquali and coworkers6 showed that
a disproportionate enlargement of the neoaortic root was
found in younger patients; at 6 years, freedom from neoaortic
reintervention was 88% whereas prior ventricular septal de-
fect closure and aortic valve replacement were associated
with an increased rate of reintervention.
The reason for these differences is not clear. Histologic
studies from dilated autografts showed the following severe
structural changes: interruption of the media and a loss of
elastin and smooth muscle cells in the vessel wall of the
pulmonary autografts.9,12,13 However, it is unclear whether
these changes would be commonly observed in all autograftsracic and Cardiovascular Surgery c Volume 136, Number 2 473
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thesis and fixed with a running suture of 4–0 Pro-
lene polypropylene at the distal (A) and proximal
(B) endings. The diameter of the Valsalva prosthe-
sis is 2 to 4 mm larger than the diameter of the pul-
monary autograft. The proximal end (collar) of the
prosthesis is trimmed, leaving only a rim of 1 to 2
mm below the sinus enlargement.subjected to systemic pressure or whether some of them may
have a pre-existing abnormality.14 Concerning the mecha-
nism of autograft degeneration, Yacoub and colleagues10
proposed that the different type of attachment of the pulmo-
nary valve leaflets, which are fixed to the muscular tissue of
the RVOT, may contribute significantly to autograft dilata-
tion. In contrast to the aortic valve, where the leaflets are at-
tached to awell-defined crown-like fibrous annulus, muscular
Figure 2. A standard technique of complete root replacement with
running sutures is used for the implantation of the autograft. The
coronary ostia are implanted with a running suture after use of
an aortic punch for making buttonholes (arrow) into the Valsalva
graft and pulmonary autograft.474 The Journal of Thoracic and Cardiovascular Surgery c Augtissue of the RVOT extends along the proximal part of each
cusp of the pulmonary valve. Inasmuch as the infundibular
muscle attached to the autograft may become ischemic after
procurement, its support to the region of pulmonary sinuses
may be lost. Scalloping of the lower end of the autograft,
leaving minimal amount of muscular tissue, and inserting
this region inside the aortic annulus may help to minimize
the risk of late dilatation.
The original description of the Ross procedure recommen-
ded suturing the autograft in a subcoronary position, which
did not allow long-term dilatation. Sievers and coworkers15
reported the results with this technique in 347 patients. In 4
patients the autograft had to be replaced, whereas autograft
insufficiency of grade III was present in only 4 other patients
at the last follow-up. No dilatation of the aortic root was ob-
served at all. The authors concluded that the subcoronary im-
plantation should be the first choice when a Ross procedure is
performed. However, a majority of surgeons argue that the
subcoronary implantation is technically more demanding,
especially in the presence of aortic root calcification and in
patients with true bicuspid aortic valve, in whom the ideal
TABLE 1. Size of the pulmonary and aortic root, as well as
autograft and homograft mean ischemic and perfusion
times
Mean diameter of the pulmonary autograft 23.5 6 2.1 mm
Mean diameter of the aortic anulus 21.7 6 3.1 mm
Mean diameter of the ascending aorta at
sinotubular junction
24.4 6 2.9 mm
Mean diameter of the mid–ascending aorta 29.5 6 13 mm
Mean diameter of the Valsalva graft 27.5 6 2.4 mm
Mean diameter of the pulmonary homograft 25.5 6 2.3 mm
Mean aortic crossclamp time* 71 6 16 min
Mean cardiopulmonary bypass time 95 6 27 min
*Right ventricular outflow tract reconstruction was performed on the beat-
ing heart in 5 patients.ust 2008
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to define.
A technique similar to the one described in this article has
already been described briefly in a review, but the autograft
was encased in a straight Dacron prosthetic graft, which how-
ever does not allow any pulsatility of the autograft.16 Our
modification uses a prosthetic graft with an artificial Valsalva
configuration to allow the most physiologic pressure and
flow patterns within the autograft with a complete reinforce-
ment of the pulmonary autograft. Wrapping of the pulmonary
autograft is not a completely new concept; we17 already de-
scribed the wrapping technique more than 15 years ago as
an adequate technique for older patients with a moderate di-
latation of the ascending aorta. Midterm results were very sat-
isfactory and no necrosis of the underlying ascending aortic
tissue was found in these patients when redo surgery was nec-
essary because of the migration of the reinforcement graft.
Magnetic resonance flow and pressure studies showed that
the pulsatility of the autograft is preserved within each car-
diac cycle. The artificial root region of the vascular graft
allows some pressure-related pulsatility of the autograft dur-
ing the cardiac cycle, while preventing dilatation of the auto-
graft when exposed to a systemic pressure in the long term.
In conclusion, the present technique is a simple and repro-
ducible additional step, which does not require significant
additional time. Inclusion of the autograft within an aortic
root–designed prosthetic graft may help to prevent neoaortic
root dilatation and autograft regurgitation and is especially
indicated in situations known for late autograft dilatation,
namely, bicuspid aortic valve, predominant aortic insuffi-
ciency, and ascending aortic enlargement.
Only a close follow-up will definitely be able to demon-
strate whether midterm to long-term dilatation of the pulmo-
nary autograft can be avoided through this technique.
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